Sector: Healthcare
Showing 1–100 of 5956 stocks (page 1 of 60).
| Stock | Market Cap | Dividend Yield | P/E Ratio | Dividend Frequency | Years Paying | DGR |
|---|---|---|---|---|---|---|
| 0R29.L Intuitive Surgical, Inc. | 5.5 trillion | 0.00% | 1.07 | - | - | - |
| 0KW4.L ResMed Inc. | 3.1 trillion | 1.06% | 0.40 | 4 | 9 | 7% |
| 0KSX.L Quest Diagnostics Incorporated | 2.7 trillion | 1.64% | 0.13 | 4 | 10 | 6% |
| LLY Eli Lilly and Company Contenders | 1.1 trillion | 0.61% | 35.03 | 4 | 55 | 16% |
| LLY.DE Eli Lilly and Company | 941.5 billion | 0.62% | 44.18 | 4 | 11 | 12% |
| LLY.SW LILLY ELI | 937.9 billion | 0.75% | 75.02 | 2 | - | - |
| 0JZ2.L Masimo Corporation | 933.7 billion | 0.00% | 0.45 | - | - | - |
| JNJ.DE Johnson & Johnson | 552.3 billion | 2.62% | 21.22 | 4 | 27 | 2% |
| JNJ Johnson & Johnson Champions | 548.3 billion | 2.30% | 20.91 | 4 | 26 | 5% |
| JNJ.NE JOHNSON & JOHNSON CDR (CAD HEDG | 535.0 billion | 17.68% | 20.73 | 4 | 4 | - |
| ABBV.BA AbbVie Inc. | 426.4 billion | 2.24% | 10.31 | 4 | 6 | 30% |
| NOVC.DE Novo Nordisk A/S | 404.0 billion | 1.06% | 22.93 | 2 | 22 | 12% |
| ABBV AbbVie Inc. Contenders | 401.5 billion | 2.97% | 101.05 | 4 | 14 | 6% |
| 0QQ6.L Roche Holding AG | 391.3 billion | 2.64% | 22.66 | 1 | 12 | 1% |
| UNH.BA UNITEDHEALTH GROUP INC CEDEAR E | 385.6 billion | 0.00% | 251 | - | - | - |
| ABBV.NE AbbVie Inc. | 378.6 billion | 21.77% | 159.63 | 4 | 4 | - |
| 0I3I.L The Cooper Companies, Inc. | 370.6 billion | 0.00% | 0.04 | - | - | - |
| 4AB.DE AbbVie Inc. | 360.7 billion | 3.71% | 104.03 | 4 | 11 | 2% |
| RO.SW Roche Holding AG | 351.4 billion | 2.75% | 21.99 | 1 | 32 | 1% |
| RHHVF Roche Holding AG | 349.5 billion | 2.50% | 21.83 | 1 | 37 | 26% |
| UNH UnitedHealth Group Incorporated Contenders | 343.2 billion | 2.34% | 26.81 | 4 | 37 | 12% |
| RHHBY Roche Holding AG | 331.6 billion | 3.01% | 22.25 | 1 | 34 | 3% |
| RHHBF Roche Holding AG | 324.8 billion | 3.04% | 23.47 | 2 | 25 | 26% |
| ROG.SW Roche Holding AG | 320.7 billion | 3.06% | 20.11 | 1 | 32 | 1% |
| UNH.DE UnitedHealth Group Incorporated | 315.3 billion | 2.20% | 26.57 | 4 | 19 | 10% |
| AZNCF AstraZeneca PLC | 312.8 billion | 1.56% | 33.46 | 3 | 18 | 24% |
| ZEG.DE AstraZeneca PLC | 287.3 billion | 2.00% | 29.17 | 1 | 26 | 6% |
| NVS Novartis AG Challengers | 284.6 billion | 3.18% | 21.00 | 1 | 30 | 6% |
| MRK Merck & Co., Inc. Contenders | 283.5 billion | 2.89% | 31.99 | 4 | 65 | 6% |
| 6MK.DE Merck & Co., Inc. | 280.8 billion | 2.87% | 15.71 | 4 | 27 | 3% |
| NVSEF Novartis AG | 275.0 billion | 3.29% | 21.02 | 2 | 30 | 5% |
| AZN.ST AstraZeneca PLC | 273.6 billion | 0.19% | 27.37 | 2 | 27 | 4% |
| AZN AstraZeneca PLC | 273.4 billion | 1.82% | 27.34 | 2 | 34 | 2% |
| NOVN.SW Novartis AG | 271.7 billion | 4.03% | 21.04 | 1 | 30 | 4% |
| UNH.NE UnitedHealth Group Inc | 250.7 billion | 3.01% | 14.66 | 4 | 5 | - |
| NOV.DE Novo Nordisk A/S | 207.7 billion | 29.35% | 11.07 | 2 | 25 | 4% |
| NOVO-B.CO Novo Nordisk A/S | 206.5 billion | 3.90% | 11.01 | 2 | 27 | 8% |
| SRTOY Sartorius Stedim Biotech S.A. | 199.6 billion | 0.40% | 59.31 | 1 | 6 | -30% |
| NONOF Novo Nordisk A/S | 196.3 billion | 4.08% | 10.69 | 3 | 18 | 27% |
| ABT.SW Abbott Laboratories | 195.4 billion | 1.99% | 34.62 | 3 | 26 | 14% |
| AMGN Amgen Inc. Contenders | 188.7 billion | 2.88% | 23.04 | 4 | 16 | 8% |
| TN8.DE Thermo Fisher Scientific Inc. | 187.1 billion | 0.34% | 28.60 | 3 | 10 | 13% |
| NVO Novo Nordisk A/S | 186.9 billion | 4.28% | 10.79 | 2 | 45 | 26% |
| 0R0H.L Thermo Fisher Scientific Inc. | 186.4 billion | 0.34% | 26.15 | 3 | 10 | 14% |
| TMO.NE Thermo Fisher Scientific Inc. | 183.1 billion | 0.34% | 28.54 | 3 | 3 | - |
| TMO Thermo Fisher Scientific Inc. Challengers | 175.7 billion | 0.37% | 25.65 | 4 | 15 | 14% |
| AMG.DE Amgen Inc. | 175.4 billion | 3.51% | 22.93 | 4 | 16 | 5% |
| GIS.DE Gilead Sciences, Inc. | 162.8 billion | 2.76% | 18.20 | 3 | 12 | -1% |
| GILD Gilead Sciences, Inc. Contenders | 160.2 billion | 2.47% | 18.13 | 4 | 12 | 2% |
| ABT Abbott Laboratories Contenders | 157.1 billion | 2.71% | 25.69 | 4 | 44 | 8% |
| ABL.DE Abbott Laboratories | 156.5 billion | 3.13% | 25.61 | 4 | 19 | 7% |
| PFE.DE Pfizer Inc. | 149.8 billion | 6.43% | 19.53 | 4 | 27 | 0% |
| PFE.BA Pfizer Inc. | 149.8 billion | 0.00% | 2.62 | 4 | 19 | 30% |
| PFE.F Pfizer Inc. | 148.0 billion | 7.56% | 19.41 | 4 | 17 | 2% |
| PFE.NE Pfizer Inc. | 147.4 billion | 14.14% | 14.81 | 4 | 5 | 30% |
| 0R2S.L Stryker Corporation | 146.7 billion | 0.89% | 72.89 | 4 | 11 | 7% |
| PFE Pfizer Inc. Contenders | 144.5 billion | 6.78% | 19.60 | 4 | 55 | 2% |
| 0R2B.L Danaher Corporation | 144.3 billion | 0.64% | 23.26 | 4 | 11 | 30% |
| DAP.DE Danaher Corporation | 143.5 billion | 0.63% | 41.31 | 5 | 24 | 5% |
| ISRG Intuitive Surgical, Inc. | 142.5 billion | 0.00% | 57.16 | - | - | - |
| IUI1.DE Intuitive Surgical, Inc. | 139.4 billion | 0.00% | 48.13 | - | - | - |
| 0Y6X.L Medtronic plc | 129.7 billion | 2.93% | 25.90 | 4 | 13 | 16% |
| 0J1R.L HCA Healthcare, Inc. | 126.1 billion | 0.68% | 0.21 | 4 | 9 | 16% |
| DHR Danaher Corporation Contenders | 125.4 billion | 0.77% | 34.35 | 4 | 34 | 10% |
| 0JZU.L McKesson Corporation | 122.7 billion | 0.39% | 136.66 | 4 | 10 | 12% |
| BRM.DE Bristol-Myers Squibb Company | 121.1 billion | 4.16% | 17.30 | 4 | 28 | 2% |
| VX1.DE Vertex Pharmaceuticals Incorporated | 119.0 billion | 0.00% | 31.29 | - | - | - |
| SNYNF SANOFI | 118.6 billion | 4.07% | 24.26 | 1 | 17 | 2% |
| CVS CVS Health Corporation | 118.5 billion | 2.86% | 40.45 | 4 | 42 | 6% |
| SYK Stryker Corporation Champions | 117.2 billion | 1.13% | 34.76 | 4 | 34 | 7% |
| EL.PA EssilorLuxottica S.A. | 117.1 billion | 1.80% | 42.58 | 1 | 27 | 16% |
| ANTM Anthem, Inc. | 117.1 billion | 0.85% | 25.82 | 1 | 13 | 14% |
| 0QZU.L Vertex Pharmaceuticals Incorporated | 116.6 billion | 0.00% | 47.90 | - | - | - |
| 2M6.DE Medtronic plc | 116.3 billion | 3.10% | 25.49 | 5 | 19 | -2% |
| CVS.NE CVS Health Corporation | 114.8 billion | 12.36% | 244.33 | 4 | 4 | - |
| BMY Bristol-Myers Squibb Company Contenders | 114.2 billion | 4.47% | 15.85 | 4 | 55 | 6% |
| SNW.DE Sanofi | 109.0 billion | 0.00% | 19.78 | 1 | 27 | 4% |
| VRTX Vertex Pharmaceuticals Incorporated | 108.7 billion | 0.00% | 25.51 | - | - | - |
| SAN.PA Sanofi | 108.7 billion | 0.00% | 19.78 | 1 | 27 | 4% |
| 0HOY.L Boston Scientific Corporation | 107.2 billion | 0.00% | 136.32 | - | - | - |
| SNY Sanofi | 106.8 billion | 5.46% | 19.84 | 1 | 24 | 4% |
| MDT Medtronic plc Champions | 103.6 billion | 3.48% | 21.63 | 4 | 45 | 2% |
| ESLOF ESSILORLUXOTTICA | 102.1 billion | 0.02% | 42.04 | 1 | 16 | 25% |
| 0HRS.L CVS Health Corporation | 102.0 billion | 3.30% | 13.40 | 4 | 10 | 6% |
| CVS.DE CVS Health Corporation | 101.0 billion | 3.31% | 58.34 | 4 | 10 | 6% |
| GSK GSK plc | 100.0 billion | 3.62% | 13.05 | 4 | 43 | 0% |
| GLAXF GSK plc | 98.9 billion | 3.64% | 12.96 | 7 | 23 | 9% |
| 4519.T Chugai Pharmaceutical Co., Ltd. | 98.3 billion | 1.38% | 36.36 | 2 | 27 | 30% |
| FSNUY Fresenius SE & Co. KGaA | 94.7 billion | 2.90% | 14.92 | 1 | 2 | - |
| MCK McKesson Corporation Contenders | 93.2 billion | 0.42% | 19.16 | 4 | 40 | 13% |
| ESLOY EssilorLuxottica S.A. | 90.2 billion | 2.39% | 41.16 | 1 | 22 | 18% |
| BSX.F Boston Scientific Corporation | 89.8 billion | 0.00% | 25.55 | - | - | - |
| CGN.DE The Cigna Group | 88.2 billion | 1.79% | 15.96 | 2 | 1 | - |
| ELV Elevance Health Inc. Contenders | 85.0 billion | 1.75% | 15.08 | 4 | 20 | 12% |
| 0R2M.L Regeneron Pharmaceuticals, Inc. | 83.6 billion | 0.46% | 11.01 | 4 | 2 | - |
| GSKN.MX GSK PLC | 83.0 billion | 0.00% | 9.68 | 2 | 16 | -5% |
| SOAGY Sartorius AG | 81.8 billion | 0.30% | 106.63 | 1 | 6 | - |
| HCA HCA Healthcare, Inc. | 80.6 billion | 0.81% | 14.96 | 4 | 9 | 14% |
| CI Cigna Corporation Challengers | 76.6 billion | 2.12% | 12.12 | 4 | 45 | 20% |
| CHGCY Chugai Pharmaceutical Co., Ltd. | 75.9 billion | 3.56% | 30.01 | - | - | - |